Related Experiment Video
Updated: Jun 24, 2026

Subcutaneous Angiotensin II Infusion using Osmotic Pumps Induces Aortic Aneurysms in Mice
Published on: September 28, 2015
Apelin prevents aortic aneurysm formation by inhibiting macrophage inflammation
Nicholas J Leeper1, Maureen M Tedesco, Yoko Kojima
1Division of Cardiovascular Medicine, Department of Medicine, Stanford Univ., 300 Pasteur Dr., Stanford, California 94305, USA.
Abstract:
Apelin is a potent inodilator with recently described antiatherogenic properties. We hypothesized that apelin might also attenuate abdominal aortic aneurysm (AAA) formation by limiting disease-related vascular wall inflammation. C57BL/6 mice implanted with osmotic pumps filled with apelin or saline were treated with pancreatic elastase to create infrarenal AAAs. Mice were euthanized for aortic PCR analysis or followed ultrasonographically and then euthanized for histological analysis. The cellular expression of inflammatory cytokines and chemokines in response to apelin was also assessed in cultured macrophages, smooth muscle cells, and fibroblasts. Apelin treatment resulted in diminished AAA formation, with a 47% reduction in maximal cross-sectional area (0.74 vs. 1.39 mm(2), P < 0.03) and a 57% reduction in macrophage infiltrate (113 vs. 261.3 cells/high-power field, P < 0.0001) relative to the saline-treated group. Apelin infusion was also associated with significantly reduced aortic macrophage colony-stimulating factor expression and decreased monocyte chemattractant protein (MCP)-1, macrophage inflammatory protein (MIP)-1alpha, interleukin (IL)-6, and tumor necrosis factor (TNF)-alpha mean mRNA levels. Apelin stimulation of cultured macrophages significantly reduced MCP-1 and TNF-alpha mRNA levels relative to baseline (2.03- and 1.89-fold reduction, P < 0.03, respectively) but did not affect intimal adhesion molecule expression or medial or adventitial cell cytokine production. Apelin significantly reduces aneurysm formation in the elastase model of human AAA disease. The mechanism appears to be decreased macrophage burden, perhaps related to an apelin-mediated decrease in proinflammatory cytokine and chemokine activation.
Insights
Apelin, a potent inodilator, significantly reduces abdominal aortic aneurysm (AAA) formation by decreasing vascular inflammation and macrophage infiltration. This study highlights apelin
Area of Science:
- Vascular Biology
- Cardiovascular Research
- Inflammation and Immunology
Background:
- Apelin is an inodilator with known antiatherogenic effects.
- Vascular wall inflammation is a key factor in abdominal aortic aneurysm (AAA) development.
- The potential of apelin to mitigate AAA formation by reducing inflammation requires investigation.
Purpose of the Study:
- To investigate the hypothesis that apelin attenuates abdominal aortic aneurysm (AAA) formation.
- To determine if apelin limits disease-related vascular wall inflammation in AAA.
- To assess the impact of apelin on inflammatory cell infiltration and cytokine expression in AAA.
Main Methods:
- Apelin or saline was administered to C57BL/6 mice via osmotic pumps.
- Infrarenal abdominal aortic aneurysms (AAAs) were induced using pancreatic elastase.
- Aortic dimensions and macrophage infiltration were assessed using ultrasonography and histology.
- Gene expression of inflammatory markers was analyzed via PCR in aortic tissues and cultured cells.
Main Results:
- Apelin treatment significantly reduced AAA formation, decreasing maximal cross-sectional area by 47% and macrophage infiltrate by 57%.
- Apelin infusion led to reduced expression of macrophage colony-stimulating factor, monocyte chemoattractant protein-1 (MCP-1), macrophage inflammatory protein-1alpha (MIP-1alpha), interleukin-6 (IL-6), and tumor necrosis factor-alpha (TNF-alpha).
- Apelin stimulation of cultured macrophages decreased MCP-1 and TNF-alpha mRNA levels but did not affect adhesion molecule expression or cytokine production in other vascular cells.
Conclusions:
- Apelin significantly reduces aneurysm formation in a mouse model of AAA.
- The mechanism involves a decreased macrophage burden, likely due to apelin-mediated reduction in pro-inflammatory cytokine and chemokine activation.
- Apelin demonstrates therapeutic potential for mitigating AAA development by targeting vascular inflammation.
Related Concept Videos
Inflammation
Atherosclerosis I: Introduction
Peripheral Artery Disease I: Introduction
Aneurysm I: Introduction
Antimicrobial Proteins
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
